MARKETS
Analyst Actions

BTIG Reiterates Buy on Solventum, Maintains $95 Price Target

Sep 14, 2026 · 06:29 AM ET· updated 11h ago

BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.

Share
Why It Matters

A market expert still thinks Solventum is a good company to own. They believe the stock could be worth around $95 per share.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.